Lv1
82 积分 2025-06-14 加入
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer
15天前
已完结
NOD-Like Receptors: Role in Innate Immunity and Inflammatory Disease
1个月前
已完结
Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
1个月前
已完结
Interferons, immunity and cancer immunoediting
1个月前
已完结
YAP1-Driven PLCβ1 Impairs MHC-I Antigen Presentation and Limits Anti-Tumor Immunity in Gastrointestinal Cancer
1个月前
已完结
TRIM11 potentiates antitumor immunity via inhibition of the IFN-γ/PD-L1 axis
1个月前
已完结
Matrix stiffness drives HCC invasion and metastasis via interfering with TRIM21-mediated SCD1 ubiquitination
1个月前
已完结
TRIM21-mediated ubiquitination of SQSTM1/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity
1个月前
已完结
DPP9 inhibition boosts antitumor immunity by disrupting BRISC-mediated PD-L1 expression in clear cell renal cell carcinoma
2个月前
已完结
Immune escape of head and neck cancer mediated by the impaired MHC-I antigen presentation pathway
2个月前
已完结
皖公网安备34019202002308
